Labcorp (LH)
326.89
-4.61 (1.39%)
Upcoming Events
Latest Headlines
Form 4 LABCORP HOLDINGS INC. For: Sep 01 Filed by: Oyegunwa Akinbolade
September 3, 2026 8:21 AM - SEC Filing
Form 4 LABCORP HOLDINGS INC. For: Sep 01 Filed by: Meltzer Jonathan C
September 3, 2026 8:20 AM - SEC Filing
Form 4 LABCORP HOLDINGS INC. For: Sep 01 Filed by: Vaughn Bryan T
September 3, 2026 8:19 AM - SEC Filing
Form 4 LABCORP HOLDINGS INC. For: Sep 01 Filed by: Caveney Brian J
September 3, 2026 8:07 AM - SEC Filing
Labcorp Launches Next Generation of Labcorp Global Trial Connect™ to Help Sponsors and Investigator Sites Navigate Clinical Trial Complexity
August 31, 2026 7:00 AM - PR NewsWire
Form 8-K LABCORP HOLDINGS INC. For: Aug 28
August 28, 2026 8:33 AM - SEC Filing
Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference
August 28, 2026 8:30 AM - PR NewsWire
Labcorp to offer FDA-cleared Alzheimer's blood test nationwide
August 24, 2026 7:03 AM - StreetInsider
Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings
August 24, 2026 7:03 AM - PR NewsWire
Form 4 LABCORP HOLDINGS INC. For: Aug 17 Filed by: ANDERSON KERRII B
August 18, 2026 8:11 AM - SEC Filing
Labcorp and NACHC form alliance to support community health centers
August 18, 2026 7:02 AM - StreetInsider
Labcorp and NACHC Launch Strategic Alliance to Strengthen Health Center Leadership and Advance Community Health
August 18, 2026 7:00 AM - PR NewsWire
Form 144 LABCORP HOLDINGS INC. Filed by: ANDERSON KERRII B
August 17, 2026 4:31 PM - SEC Filing
Form 8-K LABCORP HOLDINGS INC. For: Aug 17
August 17, 2026 8:03 AM - SEC Filing
Labcorp to Host Investor Day on September 10, 2026
August 17, 2026 8:00 AM - PR NewsWire
Form 8-K LABCORP HOLDINGS INC. For: Aug 11
August 14, 2026 8:55 AM - SEC Filing
Form 4 LABCORP HOLDINGS INC. For: Aug 11 Filed by: Schechter Adam H
August 12, 2026 2:31 PM - SEC Filing
Form 144 LABCORP HOLDINGS INC. Filed by: Schechter Adam H
August 11, 2026 10:07 AM - SEC Filing
Laboratory Corporation of America (LH) PT Raised to $355 at Mizuho
August 10, 2026 7:13 AM - StreetInsider
Labcorp wins FDA approval for melanoma companion diagnostic
August 10, 2026 7:01 AM - StreetInsider
Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma
August 10, 2026 7:00 AM - PR NewsWire
Form 4 LABCORP HOLDINGS INC. For: Aug 04 Filed by: Summy Amy B.
August 6, 2026 8:26 AM - SEC Filing
Form 10-Q LABCORP HOLDINGS INC. For: Jun 30
August 5, 2026 4:19 PM - SEC Filing
Form 4 LABCORP HOLDINGS INC. For: Aug 03 Filed by: Wilkinson Peter J
August 5, 2026 11:18 AM - SEC Filing
Form 144 LABCORP HOLDINGS INC. Filed by: Summy Amy B.
August 4, 2026 11:58 AM - SEC Filing
Labcorp offers new FDA-approved prostate cancer diagnostic test
August 4, 2026 7:00 AM - StreetInsider
Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer
August 4, 2026 7:00 AM - PR NewsWire
Laboratory Corporation of America (LH) PT Raised to $309 at Piper Sandler
August 4, 2026 6:55 AM - StreetInsider
Laboratory Corporation of America (LH) PT Raised to $360 at JPMorgan
August 3, 2026 7:51 AM - StreetInsider
Laboratory Corporation of America (LH) PT Raised to $338 at Morgan Stanley
July 31, 2026 8:01 AM - StreetInsider
Laboratory Corporation of America (LH) PT Raised to $352 at Baird
July 31, 2026 7:20 AM - StreetInsider
Laboratory Corporation of America (LH) PT Raised to $350 at Truist Securities
July 31, 2026 7:10 AM - StreetInsider
Laboratory Corporation of America (LH) PT Raised to $320 at Barclays
July 31, 2026 6:13 AM - StreetInsider
Labcorp (LH) Tops Q2 EPS by 20c, Beats on Revenue; Offers FY26 EPS Guidance
July 30, 2026 6:57 AM - StreetInsider
Form 8-K LABCORP HOLDINGS INC. For: Jul 30
July 30, 2026 6:53 AM - SEC Filing
Labcorp Announces 2026 Second Quarter Results; Raises Full Year 2026 Guidance
July 30, 2026 6:50 AM - PR NewsWire
Labcorp launches consumer genetic health panel for 100+ conditions
July 27, 2026 8:03 AM - StreetInsider
Labcorp Launches Marker by Labcorp™ Genetic Health Panel, Expanding Consumer Access to Hereditary Genetic Risk Testing
July 27, 2026 8:00 AM - PR NewsWire
Laboratory Corporation of America (LH) PT Raised to $338 at Baird
July 13, 2026 7:20 AM - StreetInsider
Form 8-K LABCORP HOLDINGS INC. For: Jul 08
July 10, 2026 7:32 AM - SEC Filing
Labcorp Declares Quarterly Dividend
July 9, 2026 5:07 PM - PR NewsWire
Labcorp (LH) Declares $0.72 Quarterly Dividend; 1% Yield
July 9, 2026 5:07 PM - StreetInsider
Form 4 LABCORP HOLDINGS INC. For: Jul 01 Filed by: Kyle Kathryn W
July 6, 2026 9:38 AM - SEC Filing
Form 4 LABCORP HOLDINGS INC. For: Jul 01 Filed by: Vaughn Bryan T
July 6, 2026 9:37 AM - SEC Filing
Form 144 LABCORP HOLDINGS INC. Filed by: Kyle Kathryn W
July 2, 2026 12:20 PM - SEC Filing
Form 144 LABCORP HOLDINGS INC. Filed by: Vaughn Bryan T
July 2, 2026 10:29 AM - SEC Filing
Form 144 LABCORP HOLDINGS INC. Filed by: van der Vaart Sandra D
July 1, 2026 10:03 AM - SEC Filing
Form 8-K LABCORP HOLDINGS INC. For: Jun 30
June 30, 2026 4:20 PM - SEC Filing
Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026
June 30, 2026 4:15 PM - PR NewsWire
Labcorp makes RNA-based colorectal cancer home test available nationwide
June 22, 2026 7:02 AM - StreetInsider
Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test
June 22, 2026 7:00 AM - PR NewsWire
Form 4 LABCORP HOLDINGS INC. For: Jun 08 Filed by: Kyle Kathryn W
June 10, 2026 9:02 AM - SEC Filing
Form 144 LABCORP HOLDINGS INC. Filed by: Kyle Kathryn W
June 8, 2026 12:19 PM - SEC Filing
Full Article List
